SLC12A2 and brain edema: HS, which inhibits NKCC1 expression (Huang et al., 2014; Rasmussen et al., 2015) is an efficient way to treat brain edema in clinical settings (Bhardwaj and Ulatowski, 2004; Wu et al., 2019).